300016.SZ
Beijing Beilu Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.74
−6.70%Margins
Gross margin
46.1%
EBITDA margin
17.0%
EBIT margin
12.0%
Net margin
9.9%
FCF margin
0.3%
5.3%
Return on equity
3.6%
Return on assets
5.2%
Return on invested capital
0.37x
Asset turnover
CNY 232.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026